CVS Health Corporation
CVS
$95.89
-$1.26-1.30%
NYSE
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -4.99% | 2.80% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -4.99% | 2.80% | |||
| Cost of Revenue | -7.95% | 3.44% | |||
| Gross Profit | 16.01% | -1.53% | |||
| SG&A Expenses | -3.44% | 4.26% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.46% | 3.53% | |||
| Operating Income | 149.27% | -28.67% | |||
| Income Before Tax | 190.84% | 138.89% | |||
| Income Tax Expenses | 162.52% | -408.86% | |||
| Earnings from Continuing Operations | 1.16% | 173.26% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -170.00% | 33.33% | |||
| Net Income | 0.00% | 174.04% | |||
| EBIT | 149.27% | -28.67% | |||
| EBITDA | 86.96% | -18.87% | |||
| EPS Basic | -0.23% | 173.98% | |||
| Normalized Basic EPS | 179.26% | -36.67% | |||
| EPS Diluted | -0.24% | 173.60% | |||
| Normalized Diluted EPS | 179.50% | -37.02% | |||
| Average Basic Shares Outstanding | 0.24% | 0.08% | |||
| Average Diluted Shares Outstanding | 0.16% | 0.63% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 0.00% | 2.35% | |||